Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002027 · ClinicalTrials.gov registry record · NA
Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
A NA study, sponsored by Janssen.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00002027: Completed NA study, sponsored by Janssen.
NCT00002027 is a NA study that has completed, run by Janssen. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002027, a NA study, has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of side effects as reported by patients at their visits and by frequent monitoring of hematology, biochemistries, and urinalysis.
Interventions
- DRUG Diclazuril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Phase | NA |
What the finished NCT00002027 record still lists
NCT00002027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Diclazuril is the first listed.
NCT00002027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002027 about?
NCT00002027 is a clinical study titled "Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)". To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be based on the drug's clinical results and on its anti-protozoan effects. Safety will be assessed by the occurrence of...
What is the current status of trial NCT00002027?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants.
What interventions are being tested in trial NCT00002027?
The interventions under investigation include: Diclazuril (DRUG).
Who is sponsoring clinical trial NCT00002027?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002027's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors